Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kognitos Named Sample Vendor in Two Gartner® Hype Cycles as Enterprise AI Shifts from Prompts to Governed Execution
-
Deep Isolation CEO Rod Baltzer Issues Letter to Shareholders
-
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
-
TWISTED TEA HARD ICED TEA INVENTS THE ONLY FAIR DIVORCE SETTLEMENT IN AMERICA
-
IoT Connectivity Market Rebounds as Bluetooth Shipments March Toward 8.1 Billion by 2030 and Wi-Fi 8 Enters the Spotlight
-
Confidential Submission of Draft Registration Statement for Proposed IPO in the United States
-
Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary
-
Kratos Opens New 167,000-Square-Foot Manufacturing Facility in Pennsylvania, Expanding Existing Footprint in the State
-
The Axis Agency Releases New Cultural Intelligence Report Revealing Why Traditional Multicultural Marketing No Longer Reflects How Consumers Experience Identity
-
PureSky Energy Completes Landmark $183.7MM Investment-Grade Refinancing of Multi-State Community Solar Portfolio
-
Top KingWin Ltd. Announces Trading Ticker Symbol Change to “DPU”
-
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
-
Enterprise AI Has a Document Problem. Apryse Has Built the Infrastructure to Solve It.
-
Corporate and Municipal CUSIP Request Volumes Rise in June
-
Flex for Good Surpasses $1 Million in Direct Rental Assistance, Marking a New Model for Preventing Eviction
-
AI Can Summarize Employee Feedback. A New Benchmark Shows It Doesn’t Always Understand It.
-
Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
-
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
-
Sunrun Announces Date for Second Quarter 2026 Earnings Report
-
Pasqal Appoints Hewlett Packard Enterprise's Former High Performance Computing & AI Leader as Chief Commercial Officer to Drive Quantum Deployment at Enterprise Scale
-
Octave Launches CoLabs: A Customer Innovation Program to Scale AI Across Industrial Operations
-
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
-
iQuanti Appoints Jonathan Gagliano as Chief Growth Officer, Doubling Down on Transforming AI-Driven, Outcomes-Based Marketing
-
Base Markets Announces Full Launch of Multi-Asset CFD Brokerage Platform
-
Courage Opens New York Office
-
MIRROTO Launches The Social Trading Network, Expanding Access to Copy Trading Across Emerging Markets
-
Introducing FreshSure™, a Solid Ozone Technology That Could Change How the World Eats
-
Callegra Technologies Appoints Reiley Snowden as Chief AI Architect
-
From DC to Fair Oaks Ranch: Kelli Hull Bets on Monkee's Boutique
-
Ceravindo Introduces AI-Driven Trading Platform to Support Australian Investors with Smarter Market Insights
-
Perlkonat AI Launches Next-Generation AI Crypto Trading Platform to Transform Digital Investing in 2026
-
Pursuit Announces Date for Second Quarter 2026 Earnings Release and Conference Call
-
InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis
-
New History Book Explores the Beginnings of Baptist Ministry in Vietnam, 1959-1975
-
Fixing of interest rate and refinancing triggers
-
Saitech Configures Multi-Million-Dollar NVIDIA Blackwell AI Infrastructure for a Global Financial Technology Company
-
Taiseijyu Taku Launches AI-Powered Crypto Trading Platform for Japanese Investors in 2026
-
Qzovarel Review 2026: How does it work? Worth trying
-
Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies
-
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry
-
Manufacturing Benchmarking Survey Highlights Cost Pressures and 2026 Growth Outlook
-
Judi Health™ Announces Capital Rx is Now Judi Rx™, Launches Judi Care™ and Judi Cloud™ to Power the Next Era of Health Benefits Administration and Patient Care
-
VTen Announces Drill Program at the Tanami Property, NT, Australia
-
Deer Solution Reports 140% Rise in Deer Damage This Spring
-
Curaleaf Expands Florida Presence with Edgewater Dispensary Opening
-
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
-
NEVGOLD ANNOUNCES MINERAL RESOURCE: ANTIMONY OF 29,600 TONNES MEASURED & INDICATED (0.26%) AND 48,100 TONNES INFERRED (0.18%); 100% OXIDE GOLD OF 181,400 OZS MEASURED & INDICATED AND 1,203,500
-
Peabody to Announce Results for the Quarter Ended June 30, 2026
-
CCTE's ANEEL Fuel Published in Leading Peer-Reviewed Journal, Building on Completed High-Burnup Irradiation at Idaho National Laboratory
-
Stillman Bank Selects Quinte’s CaseHUB to Strengthen Reg E Dispute Operations
